Drug–drug interaction through molecular structure similarity analysis

BACKGROUND: Drug–drug interactions (DDIs) are responsible for many serious adverse events; their detection is crucial for patient safety but is very challenging. Currently, the US Food and Drug Administration and pharmaceutical companies are showing great interest in the development of improved tool...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Vilar, Santiago, Harpaz, Rave, Uriarte, Eugenio, Santana, Lourdes, Rabadan, Raul, Friedman, Carol
Format: Artigo
Langue:Inglês
Publié: BMJ Group 2012
Sujets:
Research and Applications
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534468/
https://ncbi.nlm.nih.gov/pubmed/22647690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/amiajnl-2012-000935
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires